Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy
I Antony,
A Nitenberg,
JM Foult,
and
E Aptecar
Service d'Explorations Fonctionnelles, Institut National de la Sante de la Recherche Medicale Unite 251, Centre Hospitalier, Universitaire Xavier Bichat, Paris, France.
OBJECTIVES. This study was initiated to compare the coronary reserve in treated hypertensive patients with and without left ventricular hypertrophy with that in untreated patients. BACKGROUND. Coronary reserve is impaired in hypertensive patients with left ventricular hypertrophy and normal coronary arteries. Moreover, basal coronary resistance is elevated in hypertensive patients without left ventricular hypertrophy. METHODS. Coronary reserve was measured with a coronary Doppler catheter before and after a maximally vasodilating dose of intracoronary papaverine (peak/rest flow velocity ratio) in 16 control subjects and 37 hypertensive patients with normal epicardial coronary arteries. Among 20 untreated hypertensive patients, myocardial mass was increased in 11 (group 2a) and normal in 9 (group 2b). Seventeen patients had been treated effectively for at least 1 year; nine (group 3a) had persistent left ventricular hypertrophy, and eight (group 3b) had no left ventricular hypertrophy before treatment. Left ventricular volumes and ejection fraction were normal in all groups. RESULTS. Coronary reserve was moderately reduced in group 2b (3.5 +/- 0.6 vs. 5.2 +/- 0.8 in control subjects, p < 0.001) and markedly diminished in groups 2a and 3a (2.5 +/- 0.5 and 2.7 +/- 0.4, respectively; all p < 0.001 vs. control subjects). In group 3b, coronary reserve was comparable to that of control subjects (5.1 +/- 1.4). CONCLUSIONS. The reduction in coronary reserve observed in untreated hypertensive patients with normal myocardial mass suggests that structural abnormalities of the coronary microvasculature may occur before left ventricular hypertrophy. Treated patients with normal mass before treatment had a coronary reserve comparable to that of normotensive control subjects, whereas normalization of arterial pressure with persistent left ventricular hypertrophy was associated with a marked impairment of coronary reserve.
This article has been cited by other articles:

|
 |

|
 |
 
S. A. J. Timmer, P. Knaapen, T. Germans, P. A. Dijkmans, M. Lubberink, J. M. ten Berg, F. J. ten Cate, I. K. Russel, M. J. W. Gotte, A. A. Lammertsma, et al.
Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy
Am J Physiol Heart Circ Physiol,
July 1, 2011;
301(1):
H129 - H137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Koivuviita, R. Tertti, M. Jarvisalo, M. Pietila, J. Hannukainen, J. Sundell, P. Nuutila, J. Knuuti, and K. Metsarinne
Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease
Nephrol. Dial. Transplant.,
September 1, 2009;
24(9):
2773 - 2779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Erdogan, I. Yildirim, O. Ciftci, I. Ozer, M. Caliskan, H. Gullu, and H. Muderrisoglu
Effects of Normal Blood Pressure, Prehypertension, and Hypertension on Coronary Microvascular Function
Circulation,
February 6, 2007;
115(5):
593 - 599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Westerhof, C. Boer, R. R. Lamberts, and P. Sipkema
Cross-talk between cardiac muscle and coronary vasculature.
Physiol Rev,
October 1, 2006;
86(4):
1263 - 1308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Erdogan, H Gullu, M Caliskan, I Yildirim, D Tok, and H Muderrisoglu
Coronary flow reserve is preserved in white-coat hypertension
Heart,
August 1, 2006;
92(8):
1109 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kozakova, G. de Simone, C. Morizzo, and C. Palombo
Coronary Vasodilator Capacity and Hypertension-Induced Increase in Left Ventricular Mass
Hypertension,
February 1, 2003;
41(2):
224 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bartel, Y. a Yang, S. Muller, R. R. Wenzel, D. Baumgart, T. Philipp, and R. Erbel
Noninvasive assessment of microvascular function in arterial hypertension by transthoracic doppler harmonic echocardiography
J. Am. Coll. Cardiol.,
June 19, 2002;
39(12):
2012 - 2018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. R. Hildick-Smith and L. M. Shapiro
Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study
J. Am. Coll. Cardiol.,
November 15, 2000;
36(6):
1889 - 1896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wieneke, M. Haude, J. Ge, C. Altmann, S. Kaiser, D. Baumgart, C. von Birgelen, D. Welge, and R. Erbel
Corrected coronary flow velocity reserve: a new concept for assessing coronary perfusion
J. Am. Coll. Cardiol.,
June 1, 2000;
35(7):
1713 - 1720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Schwartzkopff and B.E Strauer
Squeezing tubes: a case of remodeling and regulation: Coronary reserve in hypertensive heart disease
Cardiovasc Res,
October 1, 1998;
40(1):
4 - 8.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Laine, O. T. Raitakari, H. Niinikoski, O.-P. Pitkanen, H. Iida, J. Viikari, P. Nuutila, and J. Knuuti
Early impairment of coronary flow reserve in young men with borderline hypertension
J. Am. Coll. Cardiol.,
July 1, 1998;
32(1):
147 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. McGill Jr, C. A. McMahan, R. E. Tracy, M. C. Oalmann, J. F. Cornhill, E. E. Herderick, and J. P. Strong
Relation of a Postmortem Renal Index of Hypertension to Atherosclerosis and Coronary Artery Size in Young Men and Women
Arterioscler Thromb Vasc Biol,
July 1, 1998;
18(7):
1108 - 1118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Okin, M. J. Roman, J. E. Schwartz, T. G. Pickering, and R. B. Devereux
Relation of Exercise-Induced Myocardial Ischemia to Cardiac and Carotid Structure
Hypertension,
December 1, 1997;
30(6):
1382 - 1388.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. L. Houghton, V. E. Smith, D. S. Strogatz, N. L. Henches, W. M. Breisblatt, and A. A. Carr
Effect of African-American Race and Hypertensive Left Ventricular Hypertrophy on Coronary Vascular Reactivity and Endothelial Function
Hypertension,
March 1, 1997;
29(3):
706 - 714.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Kozakova, C. Palombo, L. Pratali, G. Pittella, F. Galetta, and A. L'Abbate
Mechanisms of Coronary Flow Reserve Impairment in Human Hypertension: An Integrated Approach by Transthoracic and Transesophageal Echocardiography
Hypertension,
February 1, 1997;
29(2):
551 - 559.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. P. Burke, A. Farb, Y.-h. Liang, J. Smialek, and R. Virmani
Effect of Hypertension and Cardiac Hypertrophy on Coronary Artery Morphology in Sudden Cardiac Death
Circulation,
December 15, 1996;
94(12):
3138 - 3145.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. D. Frohlich, D. Aristizabal, F. Soria, and F. H. Messerli
Investigative Concerns in Demonstrating Reduced Risk from Reversing Left Ventricular Hypertrophy
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 1996;
1(1):
17 - 22.
[Abstract]
[PDF]
|
 |
|
|